Medpace Holdings, Inc. — Director's Dealing 2021

Jan 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-01-06

Reporting Person: Troendle August J. (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-06	Common Stock	M	92118	$14.41	Acquired	6575858	Indirect
2021-01-06	Common Stock	M	5925	$14.41	Acquired	6581783	Indirect
2021-01-06	Common Stock	M	65305	$16.20	Acquired	6647088	Indirect
2021-01-06	Common Stock	M	10887	$16.88	Acquired	6657975	Indirect
2021-01-06	Common Stock	M	11112	$18.23	Acquired	6669087	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-06	Employee Stock Option (Right to Buy)	$14.41	M	92118	Disposed	2021-06-10	Common Stock (92118)	Indirect
2021-01-06	Employee Stock Option (Right to Buy)	$14.41	M	5925	Disposed	2021-07-07	Common Stock (5925)	Indirect
2021-01-06	Employee Stock Option (Right to Buy)	$16.20	M	65305	Disposed	2022-03-31	Common Stock (65305)	Indirect
2021-01-06	Employee Stock Option (Right to Buy)	$16.88	M	10887	Disposed	2022-07-31	Common Stock (10887)	Indirect
2021-01-06	Employee Stock Option (Right to Buy)	$18.23	M	11112	Disposed	2023-03-31	Common Stock (11112)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	706643	Direct

Footnotes

F1: The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F2: The stock options subject to this exercise are fully vested and exercisable.